-
This Drug Wiped Out All Cancer Markers in 78% of High-Risk Patients With Smoldering Multiple Myeloma– Before They Even Got Cancer
Medical Mythbusting Commentary for September 22, 2026 Source:This Drug Wiped Out All Cancer Markers in 78% of High-Risk Patients – Before They Even Got Cancer Reference:Teclistamab versus lenalidomide-dexamethasone in high-risk smoldering multiple myeloma: a randomized phase 2 trial
-
New tool to test for early bone marrow changes know as smouldering multiple myeloma has been developed.
Medical Mythbusting Commentary for December 16, 2024 Source:‘Smoldering myeloma’: Breakthrough research could buy time for those at risk of dangerous cancer
-
Engineered megadose of measles vaccine treats multiple myeloma in phase 1 study
Madely Health Headlines Commentary for May 16, 2014 Source: Measles virus cancer therapy shows promise, prompts caution Reference: Measles virus used to treat bone marrow cancer Russell SJ, Federspiel MJ, Peng K, et al. Remission of Disseminated Cancer After Systemic Oncolytic Virotherapy. Mayo Clinic Proceedings. Published online May 13 2014